Mirion Technologies, Inc. is a global provider of radiation detection, measurement, analysis and monitoring solutions to the medical, nuclear, defense, and research end markets. The Company's segments include Medical and Technologies. The Medical segment includes products and services for radiation therapy and personal dosimetry. This segment's offerings include solutions for calibrating and/or verifying imaging, treatment machine, patient treatment plan, and patient treatment accuracy; solutions for monitoring the total amount of radiation medical staff members are exposed to over time, and products for nuclear medicine in radiation measurement, shielding, product handling, medical imaging furniture and rehabilitation. The Technologies segment includes products and services for defense, nuclear energy, laboratories and research and other industrial markets. This segment's offerings include reactor safety and control systems, and radiological search, measurement and analysis systems.
BörsenkürzelMIR
Name des UnternehmensMirion Technologies Inc
IPO-datumJun 29, 2020
CEOMr. Thomas D. Logan
Anzahl der mitarbeiter2860
WertpapierartOrdinary Share
GeschäftsjahresendeJun 29
Addresse1218 Menlo Drive
StadtATLANTA
BörseNYSE Consolidated
LandUnited States of America
Postleitzahl30318
Telefon17704322744
Websitehttps://www.mirion.com/
BörsenkürzelMIR
IPO-datumJun 29, 2020
CEOMr. Thomas D. Logan
In den vergangenen 5 Jahren wurden insgesamt
0.00
USD an Dividenden ausgeschüttet.

Keine Daten